CUA Online library

Impact of OnabotulinumtoxinA on Urinary Incontinence and Quality of Life in Patients with Neurogenic Detrusor Overactivity Due to Multiple Sclerosis
CUA Online Library. Herschorn S. 06/24/13; 31274; MP-04.02 Disclosure(s): Consultant: Astellas, Pfizer, Allergan, AMS Clinical trial investigator: Astelllas, Pfizer, Allergan
Dr. Sender Herschorn
Dr. Sender Herschorn
All contributions
Login now to access Regular content available to all registered users.
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

What's new

Standard Synthetic Mid-urethral Sling

Health Canada approves PLUVICTO™

About Us

The CUA is a national member-based organization dedicated to enabling the profession to provide the highest possible standards of urologic care by collaboratively: Fostering excellence in urologic practice through advocacy, education, research and practice support tools. Leading evidence-based clinical practice through the development of practice standards and guidelines. Providing continuous professional development for Canadian urologists along the career-path continuum. Providing leadership in public education for urologic conditions. Representing the Canadian urologic community in relationships with governments as well as national and international medical societies.
2025 ©
Canadian Urological Association
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies